AlemtuzumabEBV-positive lymphoproliferative disorder: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1350卷 / 1期

关键词：

Glycaemic Control; Liver Lesion; Alemtuzumab; Lymphopenia; Lymphoproliferative Disorder;

D O I：

10.2165/00128415-201113500-00016

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：9 / 9

相关论文

共 50 条

[1] MethotrexateEpstein–Barr virus positive lymphoproliferative disorder: case report
Reactions Weekly, 2019, 1767 (1) : 215 - 215
[2] MethotrexateEpstein-Barr virus positive lymphoproliferative disorder: case report
Reactions Weekly, 2021, 1876 (1) : 192 - 192
[3] ImatinibEpstein-Barr virus-positive lymphoproliferative disorder: case report
Reactions Weekly, 2007, 1178 (1) : 22 - 22
[4] MycophenolateEBV-positive B-cell lymphoproliferative disorder: case report
Reactions Weekly, 2018, 1710 (1) : 230 - 230
[5] MethotrexateEpstein–Barr virus positive primary adrenal lymphoproliferative disorder: case report
Reactions Weekly, 2015, 1574 (1) : 182 - 182
[6] Posttransplantation lymphoproliferative disorder: Case report
Perkowska, A
Durlik, M
Suleiman, W
Maryniak, R
Gaciong, Z
Juskowa, J
Khameneh, ZR
Szmidt, J
Lao, M
TRANSPLANTATION PROCEEDINGS, 2000, 32 (06) : 1387 - 1388
[7] MethotrexateIntraocular lymphoproliferative disorder: case report
Reactions Weekly, 2021, 1886 (1) : 260 - 260
[8] MethotrexateGastric lymphoproliferative disorder: case report
Reactions Weekly, 2016, 1595 (1) : 137 - 137
[9] ImmunosuppressantsPosttransplantation lymphoproliferative disorder: case report
Reactions Weekly, 2017, 1633 (1) : 398 - 398
[10] VedolizumabFirst report of reversible lymphoproliferative disorder: case report
Reactions Weekly, 2023, 1959 (1) : 638 - 638

← 1 2 3 4 5 →